FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

24400611000001105: Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1734501000001112 Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1734521000001117 Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79030001000001112 Adempas 2.5mg tablets (Bayer Plc) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
79030101000001113 Adempas 2.5mg tablets (Bayer Plc) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
96180101000001115 Adempas 2.5mg tablets (Merck Sharp & Dohme Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Riociguat 2.5mg tablets true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Riociguat false Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Adempas true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Riociguat true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Riociguat true Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) 84 tablet 4 x 21 tablets Has AMP True Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier
Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has AMP True Adempas 2.5mg tablets (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start